D48.119
Desmoid tumor of unspecified site
Clinical Classification Guidelines
Medical Intelligence & Overview
A desmoid tumor, also known as aggressive fibromatosis, is a rare type of benign growth that develops from connective tissue. Despite being non-cancerous, these tumors can be locally invasive, meaning they can grow into nearby tissues and structures. The ICD-10 code D48.119 refers to desmoid tumors that are of an unspecified site, indicating that the exact location of the tumor has not been specified. They can occur in various parts of the body, including the abdominal wall, limbs, or even within internal organs.
Causes & Symptoms
Clinical Causes: Genetic factors, such as mutations in the APC gene associated with familial adenomatous polyposis (FAP) History of previous injury or surgery at the tumor site Hormonal influences, especially in women during or after pregnancy Certain inherited syndromes, like Gardner's syndrome No known cause in some cases, indicating sporadic development
Key Symptoms: A painless lump or swelling in the affected area Rapid growth of the lump over weeks or months Discomfort or pain if the tumor compresses surrounding tissues or nerves Limited movement or function if the tumor impinges on muscles or joints In internal locations, symptoms may vary depending on the affected organ or structure
Diagnostic & Treatment
Diagnosis Path: Diagnosing a desmoid tumor involves a combination of medical imaging and biopsy procedures. Typically, the process includes: - Physical examination to assess the lump’s size, location, and effect on surrounding tissues. - Imaging tests such as MRI or CT scans to visualize the tumor's extent and its relationship with nearby structures. - A biopsy, where a small tissue sample is collected and examined under a microscope to confirm the diagnosis and rule out malignant tumors. Further tests might be conducted to check for associated genetic conditions or to determine the tumor's precise location.
Treatment Protocols: Management of a desmoid tumor depends on its size, location, growth rate, and the patient’s overall health. Common treatment options include: - Surgical removal of the tumor, aiming to excise it completely while preserving surrounding tissues. - Radiation therapy, which can help control local growth, especially if surgical removal is incomplete or not feasible. - Systemic therapies such as nonsteroidal anti-inflammatory drugs (NSAIDs), hormonal therapies, or targeted agents, especially for unresectable or recurring tumors. - Watchful waiting in some cases, where the tumor is monitored regularly to assess growth before intervening. Treatment approaches are usually tailored to minimize functional impairment and maximize quality of life, as desmoid tumors can often be managed successfully with multidisciplinary care.
Clinical Advice & FAQs
Billing Guidance
Is D48.119 a billable ICD-10 code?
Yes, D48.119 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D48.119?
Clinical documentation must specify the nature of Desmoid tumor of unspecified site and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
